Cost of universal immunization with Nirsevimab vs. standard of practice for infants in their first RSV season. Foggia District, Italy, 2023–2024
Open Access
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The Need for RSV Prophylaxis in LMICsPediatrics, 2024
- Nirsevimab: Alleviating the burden of RSV morbidity in young childrenJournal of Paediatrics and Child Health, 2024
- UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infantsItalian Journal of Pediatrics, 2023
- Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019The Journal of Infectious Diseases, 2022
- Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)Italian Journal of Pediatrics, 2015